Patients recovering from congestive heart failure at a New York hospital are being offered a telemonitoring system to help with medication compliance. The data collected from the system generates an e-diary of patient adherence to the prescribed drug regimen, so clinicians and doctors can monitor compliance at the patient or study group level.
For the first time, human embryonic stem cells have been cultured under chemically controlled conditions without the use of animal substances, which is essential for future clinical uses. The method has been developed by researchers at Karolinska Institutet and is presented in the journal Nature Biotechnology.
GE Healthcare has entered an alliance with CardioDx to co-develop diagnostic technologies to improve the care and management of patients with cardiovascular disease. Building on the alliance, the GE Healthymagination Fund, a new equity fund that makes investments in highly promising healthcare technology companies, has invested $5 million in CardioDx as part of a Series [...]
The recently enacted healthcare reform legislation provides up to $1 billion in tax credits and cash grants for life sciences companies with 250 or fewer employees that have made or will make “qualified investments” in “qualifying therapeutic discovery projects” during 2009 and 2010. Credits and grants will be awarded through a competitive application process which [...]
The unused segments of veins extracted to perform heart bypass operations may be a rich source of stem cells that could be used to treat damaged hearts. They also could point the way to new heart drugs. Scientists say that they derived progenitor cells from veins, multiplied them and then injected them back into mice, [...]
Scientists from Buffalo, Cleveland, and Oklahoma City made a huge step toward making the blind see, and they did it by using a form of gene therapy that does not involve the use of modified viruses. In a research report published in the April 2010 print issue of The FASEB Journal, scientists describe how they [...]
Roche intends to keep up its licensing pace even after its massive buyout of Genentech last year, which included gaining access to 16 Phase I or II programs the big Biotech had in its pipeline. Dan Zabrowski, head of partnering at the Swiss company, tells Bloomberg that Roche inked 65 deals last year and plans on pursuing just as [...]
The molecular machinery that switches on a gene known to cause breast cancer to spread and invade other organs has been identified by an international team led by scientists at The University of Texas M. D. Anderson Cancer Center. The paper was published in Nature Cell Biology’s advanced online publication.
A Columbia scientist has become the first to grow a complex, full-size bone from human adult stem cells. Gordana Vunjak-Novakovic, a professor of biomedical engineering at the Fu Foundation School of Engineering and Applied Science, reports that her team grew a temporomandibular joint (TMJ) from stem cells derived from bone marrow. Her work is reported [...]
Johns Hopkins scientists have found that a safe and inexpensive antibiotic in use since the 1970s for treating acne effectively targets infected immune cells in which HIV, the virus that causes AIDS, lies dormant and prevents them from reactivating and replicating.
You are currently browsing the weblog archives.
Longer entries are truncated. Click the headline of an entry to read it in its entirety.
Biotech Trading Signals Pharma News Biotech News